KELSEY HECKMANN: Open Payments
NPI 1275241739 · PARSIPPANY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 72 payments from 10 companies in 2025. Trend: 2023 $423 · 2024 $1,396 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $300 |
| Janssen Pharmaceuticals, Inc | 14 | $216 |
| Teva Pharmaceuticals USA, Inc. | 12 | $202 |
| ABBVIE INC. | 9 | $162 |
| Lundbeck LLC | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Tris Pharma Inc | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: ARISTADA, INVEGA SUSTENNA, VRAYLAR, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR, COBENFY, REXULTI.
Industry payments across NJ — which companies pay providers there.
